The DOI matches its Crossref record; 279 of the 279 references it cites were found in a registry or an index.
Therapeutic targeting of EPH receptors and their ligands
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Items 201–279 of 279
Vearing, C., Lee, F.-T., Wimmer-Kleikamp, S. H., Spirkoska, V., To, C., Stylianou, C., Spanevello, M., Brechbiel, M. W., Boyd, A., Scott, A. M., et al. (2005) · Cancer Research · doi:10.1158/0008-5472.can-05-0758 · Cited by 76
Self-citationChaudhari, A., Mahfouz, M. M., Fialho, A. M., Yamada, T., Granja, A. T., Zhu, Y., Hashimoto, W., Schlarb‐Ridley, B. G., Cho, W., Gupta, T. K. D., et al. (2007) · Biochemistry · doi:10.1021/bi061661x · Cited by 75
Li, J.-J., Liu, D.-P., Liu, G.-T., & Xie, D. (2009) · Oncogene · doi:10.1038/onc.2009.15 · Cited by 75
Biphasic Functions of the Kinase-defective Ephb6 Receptor in Cell Adhesion and Migration
Matsuoka, H., Obama, H., Kelly, M. L., Matsui, T., & Nakamoto, M. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m500010200 · Cited by 74
ephrinB1 signals from the cell surface to the nucleus by recruitment of STAT3
Bong, Y., Lee, H., Carim‐Todd, L., Mood, K., Nishanian, T. G., Tessarollo, L., & Daar, I. O. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0702337104 · Cited by 73
Gauthier, L., & Robbins, S. M. (2003) · Life Sciences · doi:10.1016/j.lfs.2003.09.029 · Cited by 73
Overexpression of the receptor tyrosine kinase EphA4 in human gastric cancers
Oki, M., Yamamoto, H., Taniguchi, H., Adachi, Y., Imai, K., & Shinomura, Y. (2008) · World Journal of Gastroenterology · doi:10.3748/wjg.14.5650 · Cited by 72
Ephrin A Receptors and Ligands in Lesions and Normal-Appearing White Matter in Multiple Sclerosis
Sobel, R. A. (2006) · Brain Pathology · doi:10.1111/j.1750-3639.2005.tb00098.x · Cited by 71
EphA2 Targeted Chemotherapy Using an Antibody Drug Conjugate in Endometrial Carcinoma
Lee, J., Stone, R. L., Lee, S. J., Nam, E. J., Roh, J., Nick, A. M., Han, H., Shahzad, M. M. K., Kim, H., Mangala, L. S., et al. (2010) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-10-0017 · Cited by 71
EphB4 promotes or suppresses Ras/MEK/ERK pathway in a context-dependent manner
Xiao, Z., Carrasco, R., Kinneer, K., Sabol, D., Jallal, B., Coats, S., & Tice, D. A. (2012) · Cancer Biology & Therapy · doi:10.4161/cbt.20080 · Cited by 70
EphBs: an integral link between synaptic function and synaptopathies
Sheffler-Collins, S. I., & Dalva, M. B. (2012) · Trends in Neurosciences · doi:10.1016/j.tins.2012.03.003 · Cited by 70
Fox, B. P., & Kandpal, R. P. (2009) · Oncogene · doi:10.1038/onc.2009.18 · Cited by 70
Tong, J., Elowe, S., Nash, P., & Pawson, T. J. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m208972200 · Cited by 70
Pfaff, D., Héroult, M., Riedel, M., et al. (2008) · Journal of Cell Science · doi:10.1242/jcs.030627 · Cited by 70
Lisabeth, E. M., Fernandez, C., & Pasquale, E. B. (2012) · Biochemistry · doi:10.1021/bi2014079 · Cited by 68
Effects of Cancer-Associated EPHA3 Mutations on Lung Cancer
Zhuang, G., Song, W., Amato, K. R., Hwang, Y., Lee, K., Boothby, M. R., Ye, F., Guo, Y., Shyr, Y., Lin, L., et al. (2012) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djs297 · Cited by 68
PTP1B regulates Eph receptor function and trafficking
Nievergall, E., Janes, P. W., Stegmayer, C., Vail, M. E., Haj, F. G., Teng, S. W., Neel, B. G., Bastiaens, P. I. H., & Lackmann, M. (2010) · The Journal of Cell Biology · doi:10.1083/jcb.201005035 · Cited by 68
Self-citationZhou, N., Zhao, W., Liu, D., Liang, Y., Fang, W., Li, B., & Chen, Y. (2011) · Microvascular Research · doi:10.1016/j.mvr.2011.06.005 · Cited by 67
Ashton, J. M., Balys, M. M., Neering, S. J., Hassane, D. C., Cowley, G. S., Root, D. E., Miller, P. G., Ebert, B. L., McMurray, H. R., Land, H., et al. (2012) · Cell stem cell · doi:10.1016/j.stem.2012.05.024 · Cited by 67
Non-SH2/PDZ reverse signaling by ephrins
Daar, I. O. (2011) · Seminars in Cell and Developmental Biology · doi:10.1016/j.semcdb.2011.10.012 · Cited by 65
Xi, H., & Zhao, P. (2011) · Journal of Clinical Pathology · doi:10.1136/jcp.2010.087213 · Cited by 65
Ephrin-independent regulation of cell substrate adhesion by the EphB4 receptor
Hooten, N. N., Yang, N.-Y., Silldorff, M. D., Mutyala, R., & Pasquale, E. B. (2009) · Biochemical Journal · doi:10.1042/bj20090014 · Cited by 65
Kinase Inhibitors as Potential Therapeutics for Acute and Chronic Neurodegenerative Conditions
Cuny, G. D. (2009) · Current Pharmaceutical Design · doi:10.2174/138161209789649330 · Cited by 64
Eph/ephrin Signaling as a Potential Therapeutic Target After Central Nervous System Injury
Du, J., Fu, C. T., & Sretavan, D. W. (2007) · Current Pharmaceutical Design · doi:10.2174/138161207781368594 · Cited by 63
Kitamura, T., Kabuyama, Y., Kamataki, A., Homma, Y., Kobayashi, H., Aota, S., Kikuchi, S., & Homma, Y. (2007) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00314.2007 · Cited by 61
Evidence That the EphA2 Receptor Exacerbates Ischemic Brain Injury
Thundyil, J., Manzanero, S., Pavlovski, D., Cully, T. R., Lok, K. Z., Widiapradja, A., Chunduri, P., Jo, D., Naruse, C., Asano, M., et al. (2013) · PLoS ONE · doi:10.1371/journal.pone.0053528 · Cited by 60
Dries, J. L., Kent, S. D., & Virag, J. A. I. (2011) · The Journal of Physiology · doi:10.1113/jphysiol.2010.202366 · Cited by 57
Truitt, L., & Freywald, A. (2011) · Biochemistry and Cell Biology · doi:10.1139/o10-145 · Cited by 56
Eph/ephrin signaling in epidermal differentiation and disease
Lin, S. Y., Wang, B., & Getsios, S. (2011) · Seminars in Cell and Developmental Biology · doi:10.1016/j.semcdb.2011.10.017 · Cited by 56
Figueroa, J. D., Benton, R. L., Velazquez, I., Torrado, A. I., Ortiz, C. M., Hernandez, C. M., Diaz, J. J., Magnuson, D. S. K., Whittemore, S. R., & Miranda, J. D. (2006) · Journal of Neuroscience Research · doi:10.1002/jnr.21048 · Cited by 56
Berclaz, G., Karamitopoulou, E., Mazzucchelli, L., Rohrbach, V., Dreher, E. F., Ziemiecki, A., & Andres, A. ‐. (2003) · Annals of Oncology · doi:10.1093/annonc/mdg072 · Cited by 56
Cell adhesion and EGFR activation regulate EphA2 expression in cancer
Larsen, A. B., Stockhausen, M., & Poulsen, H. S. (2009) · Cellular Signalling · doi:10.1016/j.cellsig.2009.11.018 · Cited by 55
Sakamoto, A., Sugamoto, Y., Tokunaga, Y., Yoshimuta, T., Hayashi, K., Konno, T., Kawashiri, M.-A., Takeda, Y., & Yamagishi, M. (2011) · Journal of International Medical Research · doi:10.1177/147323001103900220 · Cited by 55
Corrigan, C., Subramanian, R., & Miller, M. A. (2005) · Development · doi:10.1242/dev.02083 · Cited by 54
EphA4 deficient mice maintain astroglial–fibrotic scar formation after spinal cord injury
Herrmann, J. E., Shah, R. R., Chan, A. F., & Zheng, B. (2010) · Experimental Neurology · doi:10.1016/j.expneurol.2010.02.005 · Cited by 54
Pietanza, M. C., Lynch, T. J., Lara, P. N., Cho, J., Yanagihara, R. H., Vrindavanam, N. S., Chowhan, N. M., Gadgeel, S. M., Pennell, N. A., Funke, R. P., et al. (2011) · Journal of Thoracic Oncology · doi:10.1097/jto.0b013e31822eebf9 · Cited by 53
Ephrins Negatively Regulate Cell Proliferation in the Epidermis and Hair Follicle
Genander, M., Holmberg, J., & Frisén, J. (2010) · Stem Cells · doi:10.1002/stem.442 · Cited by 53
Transection of the Adult Rat Spinal Cord Upregulates EphB3 Receptor and Ligand Expression
Willson, C. A., Miranda, J. D., Foster, R. D., Onifer, S. M., & Whittemore, S. R. (2003) · Cell Transplantation · doi:10.3727/000000003108746830 · Cited by 53
Herath, N. I., Spanevello, M., Doecke, J. D., Smith, F. M., Pouponnot, C., & Boyd, A. (2011) · European Journal of Cancer · doi:10.1016/j.ejca.2011.07.003 · Cited by 52
Self-citationExpression and Activation of EphA4 in the Human Brain After Traumatic Injury
Frugier, T., Conquest, A., McLean, C., Currie, P. D., Moses, D., & Goldshmit, Y. (2012) · Journal of Neuropathology & Experimental Neurology · doi:10.1097/nen.0b013e3182496149 · Cited by 51
Goldshmit, Y., & Bourne, J. A. (2010) · Journal of Neurotrauma · doi:10.1089/neu.2010.1294 · Cited by 50
Tat, S. K., Pelletier, J., Amiable, N., Boileau, C., Lajeunesse, D., Duval, N., & Martel‐Pelletier, J. (2008) · Arthritis & Rheumatism · doi:10.1002/art.24029 · Cited by 50
Capillary Defects and Exaggerated Inflammatory Response in the Airways of EphA2-Deficient Mice
Okazaki, T., Ni, A., Bałuk, P., Ayeni, O. A., Kearley, J., Coyle, A. J., Humbles, A. A., & McDonald, D. M. (2009) · American Journal Of Pathology · doi:10.2353/ajpath.2009.080949 · Cited by 48
Regulation of heart valve morphogenesis by Eph receptor ligand, ephrin‐A1
Frieden, L. A., Townsend, T. A., Vaught, D., DeLaughter, D. M., Hwang, Y., Barnett, J. V., & Chen, J. (2010) · Developmental Dynamics · doi:10.1002/dvdy.22458 · Cited by 48
Månsson‐Broberg, A., Siddiqui, A. J., Genander, M., Grinnemo, K., Hao, X., Andersson, A., Wärdell, E., Sylvén, C., & Corbascio, M. (2008) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2008.06.036 · Cited by 48
Ephrin-A1-Mediated Dopaminergic Neurogenesis and Angiogenesis in a Rat Model of Parkinson's Disease
Jing, X., Miwa, H., Sawada, T., Nakanishi, I., Kondo, T., Miyajima, M., & Sakaguchi, K. (2012) · PLoS ONE · doi:10.1371/journal.pone.0032019 · Cited by 48
Expression of Eph receptors and their ligands, ephrins, during lipopolysaccharide fever in rats
Ivanov, A. I., Steiner, A. A., Scheck, A. C., & Romanovsky, A. A. (2005) · Physiological Genomics · doi:10.1152/physiolgenomics.00043.2004 · Cited by 48
Ren, Z., Chen, X., Yang, J., Kress, B. T., Tong, J., Liu, H., Takano, T., Zhao, Y., & Nedergaard, M. (2013) · Neuroscience · doi:10.1016/j.neuroscience.2013.03.010 · Cited by 47
Genet, G., Guilbeau‐Frugier, C., Honton, B., Dague, É., Schneider, M. D., Coatrieux, C., Calise, D., Cardin, C., Nieto, C., Payré, B., et al. (2012) · Circulation Research · doi:10.1161/circresaha.111.262451 · Cited by 47
Pietanza, M. C., Gadgeel, S. M., Dowlati, A., Lynch, T. J., Salgia, R., Rowland, K. M., Wertheim, M. S., Price, K. A. R., Riely, G. J., Azzoli, C. G., et al. (2012) · Journal of Thoracic Oncology · doi:10.1097/jto.0b013e31824c943f · Cited by 46
Dual targeting of EphA2 and ER restores tamoxifen sensitivity in ER/EphA2-positive breast cancer
Gökmen‐Polar, Y., Toroni, R. A., Hocevar, B. A., Badve, S., Zhao, Q., Shen, C., Bruckheimer, E., Kinch, M. S., & Miller, K. D. (2010) · Breast Cancer Research and Treatment · doi:10.1007/s10549-010-1004-y · Cited by 45
In Vivo Small-Animal PET/CT of EphB4 Receptors Using 64Cu-Labeled Peptide
Xiong, C., Huang, M. L., Zhang, R., Song, S., Lü, W., Flores, L. G., Gelovani, J. G., & Li, C. (2011) · Journal of Nuclear Medicine · doi:10.2967/jnumed.110.081943 · Cited by 45
Chan, B., & Sukhatme, V. P. (2008) · Thrombosis Research · doi:10.1016/j.thromres.2008.07.010 · Cited by 45
Exploring the Link between Germline and Somatic Genetic Alterations in Breast Carcinogenesis
Bonifaci, N., Górski, B., Masojć, B., Wokołorczyk, D., Jakubowska, A., Dębniak, T., Berenguer, A., Serra-Musach, J., Brunet, J., Dopazo, J., et al. (2010) · PLoS ONE · doi:10.1371/journal.pone.0014078 · Cited by 43
Eph/Ephrin Signalling and Function in Oncogenesis: Lessons from Embryonic Development
Janes, P. W., Adikari, S., & Lackmann, M. (2008) · Current Cancer Drug Targets · doi:10.2174/156800908785699315 · Cited by 42
Self-citationA Disalicylic Acid‐Furanyl Derivative Inhibits Ephrin Binding to a Subset of Eph Receptors
Noberini, R., De, S. K., Zhang, Z., Wu, B., Dhanya, R.-P., Chen, V., Vázquez, J., Qin, H., Song, J., Cosford, N. D. P., et al. (2011) · Chemical Biology & Drug Design · doi:10.1111/j.1747-0285.2011.01199.x · Cited by 41
Noberini, R., Mitra, S., Salvucci, O., Valencia, F., Duggineni, S., Prigozhina, N. L., Wei, K., Tosato, G., Huang, Z., & Pasquale, E. B. (2011) · PLoS ONE · doi:10.1371/journal.pone.0028611 · Cited by 40
Acute Delivery of EphA4-Fc Improves Functional Recovery after Contusive Spinal Cord Injury in Rats
Spanevello, M., Tajouri, S., Mirciov, C. S. G., Kurniawan, N. D., Pearse, M. J., Fabri, L., Owczarek, C. M., Hardy, M. P., Bradford, R. A., Ramunno, M. L., et al. (2013) · Journal of Neurotrauma · doi:10.1089/neu.2012.2729 · Cited by 39
Self-citationEph and Ephrin Interactions in Bone
Matsuo, K. (2009) · Advances in experimental medicine and biology · doi:10.1007/978-1-4419-1050-9_10 · Cited by 38
Ephrin‐A3 Suppresses Wnt Signaling to Control Retinal Stem Cell Potency
Fang, Y., Cho, K., Tchedre, K. T., Lee, S. W., Guo, C., Kinouchi, H., Fried, S. I., Sun, X., & Chen, D. F. (2012) · Stem Cells · doi:10.1002/stem.1283 · Cited by 37
Critical Role of the Axonal Guidance Cue EphrinB2 in Lung Growth, Angiogenesis, and Repair
Vadivel, A., van Haaften, T., Alphonse, R. S., Rey-Parra, G., Ionescu, L., Haromy, A., Eaton, F., Michelakis, E. D., & Thébaud, B. (2011) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201103-0545oc · Cited by 37
Sun, X., Xu, Z., Ke, Y., Hu, C., Wang, S.-Y., Ling, G., Yan, Z., Liu, Y., Song, Z., Jiang, X., et al. (2011) · Cancer Letters · doi:10.1016/j.canlet.2011.07.035 · Cited by 36
Munro, K. M., Dixon, K. J., Gresle, M. M., Jonas, A., Kemper, D., Doherty, W. O. S., Fabri, L., Owczarek, C. M., Pearse, M. J., Boyd, A., et al. (2013) · PLoS ONE · doi:10.1371/journal.pone.0055948 · Cited by 34
Self-citationLua, S., Qin, H., Lim, L., Shi, J., Gupta, G., & Song, J. (2011) · PLoS ONE · doi:10.1371/journal.pone.0027072 · Cited by 31
The Eph/ephrinB signal balance determines the pattern of T‐cell maturation in the thymus
Alfaro, D., Múñoz, J. J., García‐Ceca, J., Cejalvo, T., Jiménez, E., & Zapata, A. G. (2011) · Immunology and Cell Biology · doi:10.1038/icb.2010.172 · Cited by 31
How attraction turns to repulsion
Wilkinson, D. G. (2003) · Nature Cell Biology · doi:10.1038/ncb1003-851 · Cited by 29
Rönsch, K., Jäger, M., Schöpflin, A., Danciu, M., Laßmann, S., & Hecht, A. (2011) · Epigenetics · doi:10.4161/epi.6.5.15300 · Cited by 28
Varadé, J., Comabella, M., Ortiz, M. A., Arroyo, R., Fernández, O., Pinto-Medel, M. J., Fedetz, M., Izquierdo, G., Lucas, M., Gómez, C. L., et al. (2012) · Multiple Sclerosis Journal · doi:10.1177/1352458511432741 · Cited by 28
Matsui, C., Inoue, E., Kakita, A., Arita, K., Deguchi‐Tawarada, M., Togawa, A., Yamada, A., Takai, Y., & Takahashi, H. (2012) · Brain Pathology · doi:10.1111/j.1750-3639.2012.00587.x · Cited by 27
Wang, T., Chang, J., Ho, J., Wu, H., & Chen, T. (2011) · FEBS Journal · doi:10.1111/j.1742-4658.2011.08419.x · Cited by 27
Structural and Functional Characterization of an Agonistic Anti-Human EphA2 Monoclonal Antibody
Peng, L., Oganesyan, V., Damschroder, M. M., Wu, H., & Dall’Acqua, W. F. (2011) · Journal of Molecular Biology · doi:10.1016/j.jmb.2011.08.018 · Cited by 27
Tissue morphogenesis coupled with cell shape changes
Watanabe, T., & Takahashi, Y. (2010) · Current Opinion in Genetics & Development · doi:10.1016/j.gde.2010.05.004 · Cited by 26
Yamaguchi, S., Tatsumi, T., Takehara, T., Sasakawa, A., Hikita, H., Kohga, K., Uemura, A., Sakamori, R., Ohkawa, K., & Hayashi, N. (2008) · Cancer Immunology Immunotherapy · doi:10.1007/s00262-008-0514-5 · Cited by 26
EPHA3 as a novel therapeutic target in the hematological malignancies
Keane, N., Freeman, C. L. L., Swords, R. T., & Giles, F. J. (2012) · Expert Review of Hematology · doi:10.1586/ehm.12.19 · Cited by 26
Biervert, C., Horváth, E., & Fahrig, T. (2001) · Neuroscience Letters · doi:10.1016/s0304-3940(01)02312-6 · Cited by 23
Crystal structure of the EphA4 protein tyrosine kinase domain in the apo- and dasatinib-bound state
Farenc, C., Celie, P. H. N., Tensen, C. P., de Esch, I. J. P., & Siegal, G. (2011) · FEBS Letters · doi:10.1016/j.febslet.2011.10.028 · Cited by 22
Hånell, A., Clausen, F., Djupsjö, A., Vallstedt, A., Patra, K., Israelsson, C., Larhammar, M., Björk, M., Paixão, S., Kullander, K., et al. (2012) · Journal of Neurotrauma · doi:10.1089/neu.2012.2376 · Cited by 22
Dixon, K. J., Munro, K. M., Boyd, A., Bartlett, P. F., & Turnley, A. M. (2012) · Neuroscience Letters · doi:10.1016/j.neulet.2012.07.023 · Cited by 18
Self-citationMining the cancer genome uncovers therapeutic activity of EphA7 against lymphoma
Oricchio, E., & Wendel, H. (2012) · Cell Cycle · doi:10.4161/cc.11.6.19451 · Cited by 12
Research works printed but not linked: 26
- Marquardt, T. et al. Coexpressed EphA receptors and ephrin-A ligands mediate opposing actions on growth cone navigation from distinct membrane domains. Cell 121, 127–139 (2005). · doi:10.1016/j.cell.2005.01.020
- Gu, C. & Park, S. The EphA8 receptor regulates integrin activity through p110γ phosphatidylinositol-3 kinase in a tyrosine kinase activity-independent manner. Mol. Cell. Biol. 21, 4579–4597 (2001). · doi:10.1128/mcb.21.14.4579-4597.2001
- Wimmer-Kleikamp, S. H. et al. Elevated protein tyrosine phosphatase activity provokes Eph/ephrin-facilitated adhesion of pre-B leukemia cells. Blood 112, 721–732 (2008). · doi:10.1182/blood-2007-11-121681
- Dopeso, H. et al. The receptor tyrosine kinase EPHB4 has tumor suppressor activities in intestinal tumorigenesis. Cancer Res. 69, 7430–7438 (2009). · doi:10.1158/0008-5472.can-09-0706
- Hagey, A. et al. A recombinant antibody to EphA3 for the treatment of hematologic malignancies: research update and interim Phase 1 study results. Blood (ASH Annual Meeting Abstracts) 118, 4893 (2011).
- Dawson, D. W. et al. Global DNA methylation profiling reveals silencing of a secreted form of Epha7 in mouse and human germinal center B-cell lymphomas. Oncogene 26, 4243–4252 (2007). · doi:10.1038/sj.onc.1210211
- Wang, J. et al. Differential expression of EphA7 receptor tyrosine kinase in gastric carcinoma. Hum. Pathol. 38, 1649–1656 (2007). · doi:10.1016/j.humpath.2007.01.030
- Guan, M., Xu, C., Zhang, F. & Ye, C. Aberrant methylation of EphA7 in human prostate cancer and its relation to clinicopathologic features. Int. J. Cancer 124, 88–94 (2009). · doi:10.1002/ijc.23890
- Nievergall, E., Saunders, T. & Lackmann, M. Targeting of EPH receptor tyrosine kinases for anticancer therapy. Crit. Rev. Oncog. 17, 211–232 (2012). · doi:10.1615/critrevoncog.v17.i2.60
- Palath, V. et al. A recombinant antibody to EphA3 with pro-apoptotic and enhanced ADCC activity against various hematologic malignancies shows selective inhibition of colony formation from long-term culture-initiating cells (LTC-ICs) in primary leukemia samples. Blood (ASH Annual Meeting Abstracts) 116, 2897 (2010).
- Heroult, M. et al. EphB4 promotes site-specific metastatic tumor cell dissemination by interacting with endothelial cell-expressed ephrinB2. Mol. Cancer Res. 8, 1297–1309 (2010). · doi:10.1158/1541-7786.mcr-09-0453
- Scehnet, J. S. et al. The role of Ephs, Ephrins, and growth factors in Kaposi sarcoma and implications of EphrinB2 blockade. Blood 113, 254–263 (2009). · doi:10.1182/blood-2008-02-140020
- Noblitt, L. W., Bangari, D. S., Shukla, S., Mohammed, S. & Mittal, S. K. Immunocompetent mouse model of breast cancer for preclinical testing of EphA2-targeted therapy. Cancer Gene Ther. 12, 46–53 (2005). · doi:10.1038/sj.cgt.7700763
- Wakelee, H. A. et al. A phase I dose-escalation and pharmacokinetic (PK) study of a novel spectrum selective kinase inhibitor, XL647, in patients with advanced solid malignancies (ASM). J. Clin. Oncol. 24, Abstr. 3044 (2006). · doi:10.1200/jco.2006.24.18_suppl.3044
- Bardelle, C. et al. Inhibitors of the tyrosine kinase EphB4. Part 1: structure-based design and optimization of a series of 2,4-bis-anilinopyrimidines. Bioorg. Med. Chem. Lett. 18, 2776–2780 (2008). · doi:10.1016/j.bmcl.2008.04.015
- Jin, M. et al. Erythropoietin-producing hepatocyte B6 variant-derived peptides with the ability to induce glioma-reactive cytotoxic T lymphocytes in human leukocyte antigen-A2+ glioma patients. Cancer Sci. 99, 1656–1662 (2008). · doi:10.1111/j.1349-7006.2008.00866.x
- Irizarry-Ramirez, M. et al. Upregulation of EphA3 receptor after spinal cord injury. J. Neurotrauma 22, 929–935 (2005). · doi:10.1089/neu.2005.22.929
- Arocho, L. C. et al. Expression profile and role of EphrinA1 ligand after spinal cord injury. Cell. Mol. Neurobiol. 31, 1057–1069 (2011). · doi:10.1007/s10571-011-9705-2
- Lickliter, J. D., Smith, F. M., Olsson, J. E., Mackwell, K. L. & Boyd, A. W. Embryonic stem cells express multiple Eph-subfamily receptor tyrosine kinases. Proc. Natl Acad. Sci. USA 93, 145–150 (1996). · doi:10.1073/pnas.93.1.145
- Lazarova, P. et al. Growth factor receptors in hematopoietic stem cells: EPH family expression in CD34+ and CD133+ cell populations from mobilized peripheral blood. Int. J. Immunopathol. Pharmacol. 19, 49–56 (2006). · doi:10.1177/205873920601900105
- Luo, H., Yu, G., Tremblay, J. & Wu, J. EphB6-null mutation results in compromised T cell function. J. Clin. Invest. 114, 1762–1773 (2004). · doi:10.1172/jci21846
- Baldwin, C. et al. Upregulation of EphA2 during in vivo and in vitro renal ischemia-reperfusion injury: role of Src kinases. Am. J. Physiol. Renal Physiol. 291, F960–F971 (2006). · doi:10.1152/ajprenal.00020.2006
- Cercone, M. A., Schroeder, W., Schomberg, S. & Carpenter, T. C. EphA2 receptor mediates increased vascular permeability in lung injury due to viral infection and hypoxia. Am. J. Physiol. Lung Cell. Mol. Physiol. 297, L856–L863 (2009). · doi:10.1152/ajplung.00118.2009
- Tournoij, E. et al. The platelet P2Y12 receptor contributes to granule secretion through Ephrin A4 receptor. Platelets 23, 617–625 (2012). · doi:10.3109/09537104.2011.645924
- Hayashi, S., Asahara, T., Masuda, H., Isner, J. M. & Losordo, D. W. Functional ephrin-B2 expression for promotive interaction between arterial and venous vessels in postnatal neovascularization. Circulation 111, 2210–2218 (2005). · doi:10.1161/01.cir.0000163566.07427.73
- Zhao, X. et al. Vaccines targeting tumor blood vessel antigens promote CD8+ T cell-dependent tumor eradication or dormancy in HLA-A2 transgenic mice. J. Immunol. 188, 1782–1788 (2012). · doi:10.4049/jimmunol.1101644
Cited by
The Achilles' heel of senescent cells: from transcriptome to senolytic drugs
Zhu, Y., Tchkonia, T., Pirtskhalava, T., Gower, A. C., Ding, H., Giorgadze, N., Palmer, A. K., Ikeno, Y., Hubbard, G. B., Lenburg, M., et al. (2015) · Aging Cell · doi:10.1111/acel.12344 · Cited by 2,584
“Ephrin receptors are the largest family of receptor tyrosine kinases (Boyd et al., 2014).”
BackgroundMechanisms of ephrin–Eph signalling in development, physiology and disease
Kania, A., & Klein, R. (2016) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm.2015.16 · Cited by 643
Eph Receptors and Ephrins: Therapeutic Opportunities
Barquilla, A., & Pasquale, E. B. (2015) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev-pharmtox-011112-140226 · Cited by 294
Barcoded viral tracing of single-cell interactions in central nervous system inflammation
Clark, I. C., Gutiérrez-Vázquez, C., Wheeler, M. A., Li, Z., Rothhammer, V., Linnerbauer, M., Sanmarco, L. M., Guo, L., Blain, M., Zandee, S. E. J., et al. (2021) · Science · doi:10.1126/science.abf1230 · Cited by 285
Optimizing the safety of antibody–drug conjugates for patients with solid tumours
Tarantino, P., Ricciuti, B., Pradhan, S. M., & Tolaney, S. M. (2023) · Nature Reviews Clinical Oncology · doi:10.1038/s41571-023-00783-w · Cited by 269
Metadata
- Authors
- Boyd, A. W., Bartlett, P. F., & Lackmann, M.
- Venue
- Nature Reviews Drug Discovery
- Published
- 2013-12-31
- Volume
- 13
- Issue
- 1
- Pages
- 39-62
- ISSN
- 1474-1776 (ISSN-L)
- 1474-1784
- OpenAlex
- W2038385234
- Cited by
- 341
- References
- 279
- FWCI
- 2.14
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.